REPRIEVE

March 4, 2016

Study looks at HIV/AIDS heart risk

Several Boston-area doctors will serve as primary investigators in a worldwide study on heart disease among HIV/AIDS patients — just one deadly upshot of an illness […]
January 6, 2016

New med Could Prevent Heart Disease in People with HIV

Call it a PrEP to protect against heart disease in people with HIV.A large, multi-site clinical trial dubbed REPRIEVE has begun enrolling across the U.S. and […]
December 14, 2015

Landmark Trial to Examine Cardiovascular Treatment in HIV Patients

Over the course of their careers, many clinicians have seen HIV/AIDS progress from extremely high short-term mortality to chronic, long-term disease management. As HIV patients are […]
November 2, 2015

Sponsored by National Institutes of Health, the largest clinical trial ever focused on HIV-related cardiovascular disease is still seeking poz participants

As HIV-positive people continue living longer due to highly active antiretroviral therapy, cardiovascular disease has become a growing concern.  According to the National Institute of Allergy and […]
October 1, 2015

HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial

HIV infection is associated with increased cardiovascular disease (CVD), and increased rates of myocardial infarction and stroke have been observed in HIV-infected individuals. After traditional risk […]
October 1, 2015

Getting to the Heart of the Matter

HIV raises the risk of heart disease. What can you do to lower that risk?People with HIV are at a greater risk for heart disease than […]
August 18, 2015

Exploring Statins to Decrease HIV-Related Heart Disease Risk

Antiretroviral therapy (ART) has been a lifeline for untold numbers of patients with HIV. But as mounting evidence shows the infection may increase their risk of […]
May 1, 2015

Novel mechanisms and potential treatment strategies for CVD in HIV patients

Epidemiological studies suggest cardiovascular disease, including myocardial infarction and stroke, are increased 50% to 100% among HIV patients compared with non-HIV patients. Moreover, data suggest cardiovascular […]